Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404

European Journal of Pharmacology

Volumn 408, Issue 2, 2000, Pages 161-168

  Giuffrida, Andrea ^a   Rodriguez De Fonseca, Fernando ^b   Nava, Felice ^a   Loubet Lescoulié, Patrick ^a   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Anandamide; Anandamide transport; Cannabinoid; Fatty acid ethanolamides; High performance liquid chromatography; Mass spectrometry

Indexed keywords

ALBUMIN; ANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONYLAMIDE; N (4 HYDROXYPHENYL)ARACHIDONYLETHANOLAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOTOR ACTIVITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACIDS; MALE; MOTOR ACTIVITY; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034680851     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00786-X     Document Type: Article

References (37)

1. Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
2. Cannabinoids control spasticity and tremor in a multiple sclerosis model
3. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
4. 2-receptor responses by an anandamide transport inhibitor
5. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
6. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl-phosphatidylethanolamine, in rat brain
7. Potentiation of anandamide hypotension by the transport inhibitor, AM404
8. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
9. Control of pain initiation by endogenous cannabinoids
10. Bidirectional control of airway responsiveness by endogenous cannabinoids
11. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
12. Anandamide amidohydrolase activity in rat brain microsomes: Identification and partial characterization
13. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
14. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
15. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
16. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
17. Purification and high-resolution analysis of anandamide and other fatty acylethanolamides
18. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
19. Endogenous cannabinoid signaling and psychomotor disorders
20. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry
21. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
22. Accumulation of N-arachidonoylethanolamide (anandamide) into cerebellar granule cells occurs via facilitated diffusion
23. The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)
24. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
25. Pharmacology of cannabinoid CB1 and CB2 receptors
26. Structural determinants for recognition and traslocation by the anandamide transporter
27. The endocannabinoid system as a target for therapeutic drugs
28. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function
29. Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
30. Gel electrophoresis of cellular retinoic acid-binding protein, cellular retinol-binding protein, and serum retinol-binding protein
31. Anandamide: An endogenous activator of the vanilloid receptor
32. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
33. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes
34. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
35. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
36. The anandamide transport inhibitor AM404 activates vanilloid receptors